11 Recruiting Peripheral T Cell Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Peripheral T Cell Lymphoma
Top Recruiting Peripheral T Cell Lymphoma Studies
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
📍 Lineberger Comprehensive Cancer Center at University of North Carolina — Chapel Hill, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
📍 University of California, San Francisco Fresno — Clovis, California
View Study & Checklist ➔